Pictet Asset Management (Switzerland)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,300	Closed	-$944K	–	2069
2022 Q4	$944K	Buy	+8,300	New	+$689K	﹤0.01%	1026

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s HZNP Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 15% in Q2 2023, selling an estimated $14M and leaving 734,971 shares worth $75.6M. The position accounts for 0.09% of the portfolio, ranked #234.

Pictet Asset Management (Switzerland) first reported a position in HZNP in Q3 2021 and has held it in 8 quarters since. The position peaked at $254M in Q4 2021. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Pictet Asset Management (Switzerland) held 734,971 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $75.6M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 133,074 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $14M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.09% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #234 holding.
Pictet Asset Management (Switzerland) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $254M in Q4 2021.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.